fda glp-1 enforcement news is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified FDA GLP-1 Compounding Crackdown

Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin At a glance BPC-157 half-life / approximately 4 hours (subcutaneous or intramuscular) TB-500 half-life / longer systemic distribution, dosed 2-4 mg twice weekly IGF-1 LR3 active window / up to 20 hours vs ~20 minutes for native IGF-1 Semax mechanism / upregulates BDNF and dopamine receptor sensitivity Selank mechanism / enhances GABA-A tone and reduces IL-6 by ~30% in animal models GHRP-2 GH pulse / strong but co-elevates cortisol and prolactin Ipamorelin GH pulse / selective

1 2 3 "Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation" (PDF)

Dighriri IM, Alsubaie AM, Hakami FM, Hamithi DM, Alshekh MM, Khobrani FA, et al

This has opened the door for delivery systems that offer strong absorption with at-home convenience

BPC-157 and TB-500 for tendon injury and peptides for ligament recovery are among the recovery goals we hear